1. Home
  2. SDSTW vs INM Comparison

SDSTW vs INM Comparison

Compare SDSTW & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDSTW
  • INM
  • Stock Information
  • Founded
  • SDSTW N/A
  • INM 1981
  • Country
  • SDSTW United States
  • INM Canada
  • Employees
  • SDSTW 8
  • INM N/A
  • Industry
  • SDSTW
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SDSTW
  • INM Health Care
  • Exchange
  • SDSTW Nasdaq
  • INM Nasdaq
  • Market Cap
  • SDSTW 2.9M
  • INM 3.2M
  • IPO Year
  • SDSTW N/A
  • INM N/A
  • Fundamental
  • Price
  • SDSTW $0.09
  • INM $2.64
  • Analyst Decision
  • SDSTW
  • INM
  • Analyst Count
  • SDSTW 0
  • INM 0
  • Target Price
  • SDSTW N/A
  • INM N/A
  • AVG Volume (30 Days)
  • SDSTW 41.6K
  • INM 166.2K
  • Earning Date
  • SDSTW 03-26-2025
  • INM 05-12-2025
  • Dividend Yield
  • SDSTW N/A
  • INM N/A
  • EPS Growth
  • SDSTW N/A
  • INM N/A
  • EPS
  • SDSTW N/A
  • INM N/A
  • Revenue
  • SDSTW N/A
  • INM $4,920,990.00
  • Revenue This Year
  • SDSTW N/A
  • INM N/A
  • Revenue Next Year
  • SDSTW N/A
  • INM N/A
  • P/E Ratio
  • SDSTW N/A
  • INM N/A
  • Revenue Growth
  • SDSTW N/A
  • INM N/A
  • 52 Week Low
  • SDSTW $0.10
  • INM $1.72
  • 52 Week High
  • SDSTW $0.12
  • INM $15.70
  • Technical
  • Relative Strength Index (RSI)
  • SDSTW N/A
  • INM 45.20
  • Support Level
  • SDSTW N/A
  • INM $2.56
  • Resistance Level
  • SDSTW N/A
  • INM $2.75
  • Average True Range (ATR)
  • SDSTW 0.00
  • INM 0.17
  • MACD
  • SDSTW 0.00
  • INM -0.03
  • Stochastic Oscillator
  • SDSTW 0.00
  • INM 11.11

About SDSTW Stardust Power Inc. Warrant

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: